Dr. Jon Adleberg, M.D

NPI: 1710981246
Total Payments
$34,587
2024 Payments
$875.93
Companies
23
Transactions
228
Medicare Patients
7,655
Medicare Billing
$5.0M

Payment Breakdown by Category

Consulting$20,292 (58.7%)
Food & Beverage$6,821 (19.7%)
Research$4,625 (13.4%)
Travel$2,740 (7.9%)
Education$92.99 (0.3%)
Other$14.76 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $20,292 5 58.7%
Food and Beverage $6,821 203 19.7%
Unspecified $4,625 3 13.4%
Travel and Lodging $2,740 15 7.9%
Education $92.99 1 0.3%
Entertainment $14.76 1 0.0%

Payments by Type

General
$29,962
225 transactions
Research
$4,625
3 transactions

Top Paying Companies

Company Total Records Latest Year
Cardinal Health 108 LLC $18,075 17 $0 (2020)
Allergan, Inc. $5,824 29 $0 (2020)
Alimera Sciences, Inc. $5,787 50 $0 (2024)
Regeneron Healthcare Solutions, Inc. $825.86 19 $0 (2024)
Genentech USA, Inc. $614.98 18 $0 (2024)
Mallinckrodt Hospital Products Inc. $579.14 16 $0 (2024)
Apellis Pharmaceuticals, Inc. $513.50 12 $0 (2024)
ABBVIE INC. $365.48 21 $0 (2024)
Novartis Pharmaceuticals Corporation $345.41 6 $0 (2021)
Biogen, Inc. $342.29 7 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $875.93 30 Apellis Pharmaceuticals, Inc. ($215.15)
2023 $1,138 36 AbbVie Inc. ($171.20)
2022 $914.55 34 Alimera Sciences, Inc. ($252.20)
2021 $963.56 27 Mallinckrodt Hospital Products Inc. ($301.58)
2020 $6,520 13 Cardinal Health 108 LLC ($6,225)
2019 $9,493 22 Cardinal Health 108, LLC ($8,864)
2018 $9,764 53 Allergan Inc. ($5,702)
2017 $4,917 13 Alimera Sciences, Inc. ($4,458)

All Payment Transactions

228 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
12/11/2024 Sandoz Inc. Cimerli (Biological) Food and Beverage In-kind items and services $24.81 General
Category: Ophthalmology
11/25/2024 Alimera Sciences, Inc. ILUVIEN (Drug), YUTIQ Food and Beverage In-kind items and services $21.12 General
Category: treatment of diabetic macular edema in patients who have been previously treated with corticosteroid
11/20/2024 Harrow Eye, LLC IHEEZO (Drug), TRIESENCE Food and Beverage In-kind items and services $28.96 General
Category: OPTOMETRY
11/14/2024 Apellis Pharmaceuticals, Inc. Syfovre (Drug) Food and Beverage In-kind items and services $32.07 General
Category: Ophthalmology
11/07/2024 Astellas Pharma US Inc Izervay (Drug) Food and Beverage In-kind items and services $31.29 General
Category: Ophthalmology
11/04/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $41.34 General
Category: IMMUNOLOGY
10/30/2024 Genentech USA, Inc. Vabysmo (Drug) Food and Beverage In-kind items and services $25.74 General
Category: Immunology and Ophthalmology
09/10/2024 Apellis Pharmaceuticals, Inc. Syfovre (Drug) Food and Beverage In-kind items and services $28.60 General
Category: Ophthalmology
08/27/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $26.99 General
Category: IMMUNOLOGY
08/19/2024 Genentech USA, Inc. Vabysmo (Drug) Food and Beverage In-kind items and services $19.25 General
Category: Immunology and Ophthalmology
08/14/2024 Sandoz Inc. Cimerli (Biological) Food and Beverage In-kind items and services $31.40 General
Category: Ophthalmology
07/10/2024 Apellis Pharmaceuticals, Inc. Syfovre (Drug) Food and Beverage In-kind items and services $20.91 General
Category: Ophthalmology
07/09/2024 Sandoz Inc. Cimerli (Biological) Food and Beverage In-kind items and services $33.34 General
Category: Ophthalmology
07/02/2024 ABBVIE INC. OZURDEX (Drug) Food and Beverage In-kind items and services $16.58 General
Category: EYE CARE
06/25/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $18.67 General
Category: IMMUNOLOGY
06/17/2024 Apellis Pharmaceuticals, Inc. Syfovre (Drug) Food and Beverage In-kind items and services $29.42 General
Category: Ophthalmology
06/11/2024 Apellis Pharmaceuticals, Inc. Syfovre (Drug) Food and Beverage In-kind items and services $26.97 General
Category: Ophthalmology
06/03/2024 Sandoz Inc. Cimerli (Biological) Food and Beverage In-kind items and services $29.70 General
Category: Ophthalmology
05/29/2024 Biogen, Inc. BYOOVIZ (Biological) Food and Beverage In-kind items and services $113.03 General
Category: Ophthalmology
05/21/2024 Biogen, Inc. BYOOVIZ (Biological) Food and Beverage In-kind items and services $26.41 General
Category: Ophthalmology
05/14/2024 Apellis Pharmaceuticals, Inc. Syfovre (Drug) Food and Beverage In-kind items and services $26.64 General
Category: Ophthalmology
04/25/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $33.04 General
Category: IMMUNOLOGY
04/02/2024 Apellis Pharmaceuticals, Inc. Syfovre (Drug) Food and Beverage In-kind items and services $26.88 General
Category: Ophthalmology
03/26/2024 Genentech USA, Inc. Vabysmo (Drug) Food and Beverage In-kind items and services $29.80 General
Category: Immunology and Ophthalmology
03/12/2024 Regeneron Healthcare Solutions, Inc. EYLEA (Biological), EYLEA HD Food and Beverage In-kind items and services $17.78 General
Category: OPHTHALMOLOGY

Research Studies & Clinical Trials

Study Name Company Amount Records
PALADIN Alimera Sciences, Inc. $4,625 3

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 16 1,922 11,698 $2.9M $1.1M
2022 14 1,844 5,639 $3.1M $1.1M
2021 13 1,881 5,816 $3.5M $1.3M
2020 14 2,008 5,963 $3.9M $1.5M
Total Patients
7,655
Total Services
29,116
Medicare Billing
$5.0M
Procedure Codes
57

All Medicare Procedures & Services

57 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J0178 Injection, aflibercept, 1 mg Office 2023 92 622 $1.2M $430,200 36.0%
Q5128 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg Office 2023 54 895 $461,820 $194,426 42.1%
J2777 Injection, faricimab-svoa, 0.1 mg Office 2023 17 5,880 $447,586 $168,891 37.7%
92012 Established patient problem focused exam of visual system Office 2023 403 966 $171,297 $60,300 35.2%
67028 Injection of drug into eye Office 2023 175 703 $167,914 $59,467 35.4%
92134 Imaging of retina Office 2023 535 1,586 $131,330 $45,338 34.5%
92014 Established patient complete exam of visual system Office 2023 334 502 $127,292 $41,498 32.6%
J3590 Unclassified biologics Office 2023 23 38 $100,844 $41,123 40.8%
J2781 Injection, pegcetacoplan, intravitreal, 1 mg Office 2023 11 165 $49,620 $19,860 40.0%
92004 New patient complete exam of visual system Office 2023 79 79 $23,961 $7,550 31.5%
92250 Photography of the retina Office 2023 83 111 $11,357 $2,990 26.3%
92235 Exam of retinal blood vessels using a special camera after injection of a dye Office 2023 17 17 $3,233 $1,575 48.7%
J9035 Injection, bevacizumab, 10 mg Office 2023 15 22 $8,800 $1,180 13.4%
92201 Extended exam of the back part of the eye with retinal drawing Office 2023 62 70 $4,200 $1,153 27.5%
67515 Injection of drug or substance into membrane covering eyeball Office 2023 11 15 $2,395 $542.43 22.6%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2023 11 27 $86.40 $21.08 24.4%
J0178 Injection, aflibercept, 1 mg Office 2022 128 1,100 $2.1M $791,544 37.5%
J2778 Injection, ranibizumab, 0.1 mg Office 2022 20 406 $295,790 $91,387 30.9%
92012 Established patient problem focused exam of visual system Office 2022 393 1,032 $182,570 $64,612 35.4%
67028 Injection of drug into eye Office 2022 162 682 $162,616 $57,962 35.6%
92134 Imaging of retina Office 2022 538 1,609 $133,423 $46,762 35.0%
92014 Established patient complete exam of visual system Office 2022 324 465 $118,203 $39,004 33.0%
67210 Destruction of growth of retina using a laser Office 2022 20 27 $28,915 $10,636 36.8%
67042 Removal of membrane of retina with removal of internal limiting membrane of retina Facility 2022 12 12 $28,048 $10,460 37.3%
92004 New patient complete exam of visual system Office 2022 87 87 $26,506 $9,415 35.5%

About Dr. Jon Adleberg, M.D

Dr. Jon Adleberg, M.D is a Specialist healthcare provider based in Chesapeake, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1710981246.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jon Adleberg, M.D has received a total of $34,587 in payments from pharmaceutical and medical device companies, with $875.93 received in 2024. These payments were reported across 228 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($20,292).

As a Medicare-enrolled provider, Adleberg has provided services to 7,655 Medicare beneficiaries, totaling 29,116 services with total Medicare billing of $5.0M. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.

Practice Information

  • Specialty Specialist
  • Other Specialties Specialist, Ophthalmology
  • Location Chesapeake, VA
  • Active Since 06/13/2005
  • Last Updated 05/15/2017
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • NPI Number 1710981246

Products in Payments

  • OZURDEX (Drug) $6,092
  • ILUVIEN (Biological) $4,375
  • ILUVIEN (Drug) $603.12
  • ACTHAR (Biological) $599.72
  • Iluvien (Drug) $459.77
  • EYLEA (Biological) $427.13
  • EYLEA AFLIBERCEPT INJECTION (Biological) $398.73
  • Syfovre (Drug) $367.82
  • Cimerli (Biological) $354.48
  • Lucentis (Biological) $292.76
  • Vabysmo (Drug) $287.81
  • BEOVU (Drug) $236.10
  • Spectralis (Device) $214.86
  • BYOOVIZ (Biological) $152.55
  • XIPERE (Drug) $148.27
  • ForeseeHome (Device) $133.22
  • Jetrea (Drug) $83.26
  • Iluvien (Biological) $83.25
  • ARGOS (Device) $57.07
  • YUTIQ (Drug) $48.57

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Chesapeake